Callos Andrew sold CYTK

June 1, 2026 · Form 4 insider transaction

Callos Andrew sold 15,000 shares of Cytokinetics, Incorporated at $74.08 per share, a transaction worth $1.11M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.